Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID ‐19 mRNA vaccine‐related interstitial lung disease: Two case reports and literature review

23 Mar 2022

Abstract excerpt

The Pfizer-BioNTech mRNA vaccine (BNT162b2) is an effective and well-tolerated coronavirus disease 2019 (COVID-19) vaccine. However, rare adverse events have been reported. We report two cases of COVID-19 mRNA vaccine-related interstitial lung disease (ILD). A 67-year-old man and a 70-year-old man with underlying ILD presented to our hospital with a few days of fever and respiratory symptoms after receiving the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Polyomavirus and related diseases
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35355663
DOI: 10.1002/rcr2.938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID ‐19 mRNA vaccine‐related interstitial lung disease: Two case reports and literature reviewPMID 35355663Read ↗

Cutaneous Reactions after COVID-19 Vaccines – Analysis of the Clinical and Histological Spectrum – Case Series and Review of the LiteratureSemantic proximity Read ↗

Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA VaccineSemantic proximity Read ↗

Effect of mRNA vaccination on pulmonary sequelae after mild COVID-19Semantic proximity Read ↗

Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVacSemantic proximity Read ↗

Rapid Progressive Systemic Sclerosis Following mRNA COVID-19 VaccinationSemantic proximity Read ↗

Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genesSemantic proximity Read ↗

COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement.Semantic proximity Read ↗

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case reportSemantic proximity Read ↗

Cutaneous lymphocytic vasculitis after administration of COVID ‐19 mRNA vaccineSemantic proximity Read ↗

Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional studySemantic proximity Read ↗

New onset rheumatoid arthritis with refractory hyper-eosinophilia associated with inactivated COVID-19 vaccineSemantic proximity Read ↗

Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.